方大B(200055):2022年半年度财务报告(英文版)
|
时间:2022年08月29日 20:01:50 中财网 |
|
原标题:方大B:2022年半年度财务报告(英文版)
China Fangda Group Co., Ltd.
CHINA FANGDA GROUP CO., LTD.
2022 Financial Statements
August 2022
I. Auditor's report
Whether the interim report is audited
□ Yes ? No
The financial statements for H1 2014 have not been audited. II. Financial statements
Unit for statements in notes to financial statements: RMB yuan 1. Consolidated Balance Sheet
Prepared by: China Fangda Group Co., Ltd.
June 30, 2022
In RMB
Item | June 30, 2022 | January 1, 2022 | Current asset: | | | Monetary capital | 1,031,315,109.82 | 1,287,563,759.32 | Settlement provision | | | Outgoing call loan | | | Transactional financial assets | 32,133,168.82 | 25,135,241.89 | Derivative financial assets | 1,768,884.99 | 1,069,587.62 | Notes receivable | 157,195,531.26 | 166,377,880.01 | Account receivable | 555,641,568.67 | 556,453,824.20 | Receivable financing | 19,031,714.87 | 4,263,500.00 | Prepayment | 23,250,383.96 | 23,022,485.03 | Insurance receivable | | | Reinsurance receivable | | | Provisions of Reinsurance
contracts receivable | | | Other receivables | 179,462,261.72 | 165,093,406.23 | Including: interest
receivable | | | Dividend receivable | | | Repurchasing of financial
assets | | | Inventory | 718,612,534.55 | 733,280,924.98 | Contract assets | 2,047,054,849.24 | 1,782,947,673.13 | Assets held for sales | | | Non-current assets due in 1
year | | | Other current assets | 369,087,895.76 | 264,786,506.29 | Total current assets | 5,134,553,903.66 | 5,009,994,788.70 | Non-current assets: | | | Loan and advancement provided | | | Debt investment | | | Other debt investment | | | Long-term receivables | | | Long-term share equity
investment | 55,185,971.99 | 55,218,946.14 | Investment in other equity
tools | 14,180,652.65 | 14,180,652.65 | Other non-current financial
assets | 7,504,750.83 | 7,525,408.24 | Investment real estate | 5,763,260,414.20 | 5,765,352,393.13 | Fixed assets | 681,823,427.57 | 663,414,297.61 | Construction in process | 2,839,581.23 | 11,642,444.21 | Productive biological assets | | | Gas & petrol | | | Use right assets | 25,002,936.05 | 31,440,856.54 | Intangible assets | 73,780,578.87 | 75,199,712.83 | R&D expense | | | Goodwill | | | Long-term amortizable expenses | 5,509,790.78 | 5,388,770.22 | Deferred income tax assets | 222,694,829.06 | 214,123,733.00 | Other non-current assets | 425,168,945.51 | 407,856,515.39 | Total of non-current assets | 7,276,951,878.74 | 7,251,343,729.96 | Total of assets | 12,411,505,782.40 | 12,261,338,518.66 | Current liabilities | | | Short-term loans | 1,622,891,137.62 | 1,287,474,398.65 | Loans from Central Bank | | | Call loan received | | | Transactional financial
liabilities | | | Derivative financial
liabilities | 1,840,691.89 | 11,871.20 | Notes payable | 729,693,080.61 | 849,445,299.09 | Account payable | 1,297,629,112.02 | 1,343,123,485.97 | Prepayment received | 2,850,390.49 | 1,280,482.93 | Contract liabilities | 172,157,564.27 | 180,186,877.15 | Selling of repurchased
financial assets | | | Deposit received and held for
others | | | Entrusted trading of securities | | | Entrusted selling of securities | | | Employees' wage payable | 32,750,268.63 | 69,071,013.95 | Taxes payable | 64,570,722.30 | 67,280,647.22 | Other payables | 114,272,250.22 | 126,903,098.08 | Including: interest payable | | | Dividend payable | | | Fees and commissions payable | | | Reinsurance fee payable | | | Liabilities held for sales | | | Non-current liabilities due in
1 year | 81,922,494.73 | 78,418,557.76 | Other current liabilities | 58,546,129.52 | 48,098,361.77 | Total current liabilities | 4,179,123,842.30 | 4,051,294,093.77 | Non-current liabilities: | | | Insurance contract provision | | | Long-term loans | 1,298,500,000.00 | 1,333,500,000.00 | Bond payable | | | Including: preferred stock | | | Perpetual bond | | | Lease liabilities | 15,837,405.86 | 19,152,093.31 | Long-term payable | 190,640,219.18 | 183,640,219.18 | Long-term employees' wage
payable | | | Anticipated liabilities | 3,052,064.92 | 6,347,809.40 | Deferred earning | 9,283,203.02 | 9,566,525.60 | Deferred income tax liabilities | 1,063,619,814.66 | 1,066,631,858.80 | Other non-current liabilities | | | Total of non-current liabilities | 2,580,932,707.64 | 2,618,838,506.29 | Total liabilities | 6,760,056,549.94 | 6,670,132,600.06 | Owner's equity: | | | Share capital | 1,073,874,227.00 | 1,073,874,227.00 | Other equity tools | | | Including: preferred stock | | | Perpetual bond | | | Capital reserves | 11,459,588.40 | 11,459,588.40 | Less: Shares in stock | | | Other miscellaneous income | 34,875,541.51 | 35,325,871.78 | Special reserves | | | Surplus reserve | 79,324,940.43 | 79,324,940.43 | Common risk provisions | | | Retained profit | 4,383,046,821.75 | 4,324,055,259.33 | Total of owner's equity belong to
the parent company | 5,582,581,119.09 | 5,524,039,886.94 | Minor shareholders' equity | 68,868,113.37 | 67,166,031.66 | Total of owners' equity | 5,651,449,232.46 | 5,591,205,918.60 | Total of liabilities and owner's
interest | 12,411,505,782.40 | 12,261,338,518.66 |
Legal representative: Xiong Jianming CFO: Lin Kebing Accounting Manager: Wu Bohua 2. Balance Sheet of the Parent Company
Item | June 30, 2022 | January 1, 2022 | Current asset: | | | Monetary capital | 162,952,516.84 | 111,848,536.84 | Transactional financial assets | | | Derivative financial assets | | | Notes receivable | | | Account receivable | 790,774.65 | 585,936.30 | Receivable financing | | | Prepayment | 101,866.62 | 212,807.30 | Other receivables | 1,821,626,998.78 | 1,276,731,665.95 | Including: interest
receivable | | | Dividend receivable | | | Inventory | | | Contract assets | | | Assets held for sales | | | Non-current assets due in 1
year | | | Other current assets | 999,205.42 | 1,460,846.55 | Total current assets | 1,986,471,362.31 | 1,390,839,792.94 | Non-current assets: | | | Debt investment | | | Other debt investment | | | Long-term receivables | | | Long-term share equity
investment | 1,196,831,253.00 | 1,196,831,253.00 | Investment in other equity
tools | 14,180,652.65 | 14,180,652.65 | Other non-current financial
assets | 30,000,001.00 | 30,000,001.00 | Investment real estate | 329,471,982.00 | 329,471,982.00 | Fixed assets | 69,846,546.46 | 71,830,252.61 | Construction in process | | | Productive biological assets | | | Gas & petrol | | | Use right assets | 13,910,463.05 | 17,224,771.47 | Intangible assets | 1,136,656.32 | 1,219,737.85 | R&D expense | | | Goodwill | | | Long-term amortizable expenses | 89,888.18 | 218,563.44 | Deferred income tax assets | 28,793,169.88 | 27,079,997.63 | Other non-current assets | | | Total of non-current assets | 1,684,260,612.54 | 1,688,057,211.65 | Total of assets | 3,670,731,974.85 | 3,078,897,004.59 | Current liabilities | | | Short-term loans | 300,052,500.00 | 300,351,666.67 | Transactional financial
liabilities | | | Derivative financial
liabilities | | | Notes payable | | | Account payable | 1,115,393.82 | 606,941.85 | Prepayment received | 832,154.41 | 858,019.63 | Contract liabilities | | | Employees' wage payable | 1,536,881.97 | 3,909,857.23 | Taxes payable | 861,765.79 | 3,447,040.12 | Other payables | 892,974,754.71 | 233,531,740.37 | Including: interest payable | | | Dividend payable | | | Liabilities held for sales | | | Non-current liabilities due in
1 year | 3,532,955.72 | 4,264,397.66 | Other current liabilities | | | Total current liabilities | 1,200,906,406.42 | 546,969,663.53 | Non-current liabilities: | | | Long-term loans | | | Bond payable | | | Including: preferred stock | | | Perpetual bond | | | Lease liabilities | 11,228,293.71 | 13,560,947.50 | Long-term payable | | | Long-term employees' wage
payable | | | Anticipated liabilities | | | Deferred earning | | | Deferred income tax liabilities | 74,263,872.99 | 74,447,416.01 | Other non-current liabilities | | | Total of non-current liabilities | 85,492,166.70 | 88,008,363.51 | Total liabilities | 1,286,398,573.12 | 634,978,027.04 | Owner's equity: | | | Share capital | 1,073,874,227.00 | 1,073,874,227.00 | Other equity tools | | | Including: preferred stock | | | Perpetual bond | | | Capital reserves | 360,835.52 | 360,835.52 | Less: Shares in stock | | | Other miscellaneous income | -520,786.11 | -520,786.11 | Special reserves | | | Surplus reserve | 79,324,940.43 | 79,324,940.43 | Retained profit | 1,231,294,184.89 | 1,290,879,760.71 | Total of owners' equity | 2,384,333,401.73 | 2,443,918,977.55 | Total of liabilities and owner's
interest | 3,670,731,974.85 | 3,078,897,004.59 |
3. Consolidated Income Statement
In RMB
Item | H1 2022 | H1 2021 | 1. Total revenue | 1,613,063,315.30 | 1,568,778,834.98 | Incl. Business income | 1,613,063,315.30 | 1,568,778,834.98 | Interest income | | | Insurance fee earned | | | Fee and commission
received | | | 2. Total business cost | 1,492,648,248.55 | 1,464,915,772.96 | Incl. Business cost | 1,259,515,842.60 | 1,208,641,803.18 | Interest expense | | | Fee and commission paid | | | Insurance discharge
payment | | | Net claim amount paid | | | Net insurance policy
responsibility reserves provided | | | Insurance policy dividend
paid | | | Reinsurance expenses | | | Taxes and surcharges | 23,203,954.56 | 35,853,693.88 | Sales expense | 23,296,105.78 | 25,434,914.81 | Administrative expense | 74,193,251.57 | 69,502,453.93 | R&D cost | 72,809,311.17 | 78,645,594.86 | Financial expenses | 39,629,782.88 | 46,837,312.30 | Including: interest
cost | 50,244,714.46 | 43,637,100.05 | Interest income | 19,918,179.96 | 6,976,161.44 | Add: other gains | 6,768,907.75 | 6,607,058.06 | Investment gains (“-” for
loss) | 4,595,678.43 | -532,743.54 | Incl. Investment gains
from affiliates and joint
ventures | -32,974.15 | -452,893.65 | Financial assets
derecognised as a result of
amortized cost | -1,859,057.85 | -3,032,899.72 | Exchange gains ("-" for
loss) | | | Net open hedge gains (“-”
for loss) | | | Gains from change of fair
value (“-“ for loss) | 1,180,840.01 | 172,829.74 | Credit impairment ("-" for
loss) | 25,016,298.34 | 19,853,416.06 | Investment impairment loss
("-" for loss) | -27,659,612.75 | 3,466,913.89 | Investment gains ("-" for
loss) | -815,581.50 | - 2 ,027,304.03 | 3. Operational profit ("-" for
loss) | 129,501,597.03 | 131,403,232.20 | Plus: non-operational income | 446,386.82 | 1 , 2 01 ,106.46 | Less: non-operational
expenditure | 2,578,001.31 | 3 ,480,374.51 | 4. Gross profit ("-" for loss) | 127,369,982.54 | 129,123,964.15 | Less: Income tax expenses | 13,005,121.74 | 13,936,493.66 | 5. Net profit ("-" for net loss) | 114,364,860.80 | 115,187,470.49 | (1) By operating consistency | | | 1. Net profit from continuous
operation ("-" for net loss) | 114,364,860.80 | 115,187,470.49 | 2. Net profit from
discontinuous operation ("-" for
net loss) | | | (2) By ownership | | | 1. Net profit attributable to
the owners of parent company | 112,685,273.77 | 111,488,701.33 | 2. Minor shareholders' equity | 1,679,587.03 | 3,698,769.16 | 6. After-tax net amount of other
misc. incomes | -427,835.59 | -24,854.15 | After-tax net amount of other
misc. incomes attributed to
parent's owner | -450,330.27 | -1,460.74 | (1) Other misc. incomes that
cannot be re-classified into gain
and loss | | -229,678.59 | 1. Re-measure the change in
the defined benefit plan | | | 2. Other comprehensive
income that cannot be transferred
to profit or loss under the
equity method | | | 3. Fair value change of
investment in other equity tools | | -229,678.59 | 4. Fair value change of the
Company's credit risk | | | 5. Others | | | (2) Other misc. incomes that
will be re-classified into gain
and loss | -450,330.27 | 228,217.85 | 1. Other comprehensive
income that can be transferred to
profit or loss under the equity
method | | | 2. Fair value change of
other debt investment | | | 3. Gains and losses from
changes in fair value of
available-for-sale financial
assets | | | 4. Other credit investment
credit impairment provisions | | | 5. Cash flow hedge reserve | -960,094.83 | -785,690.88 | 6. Translation difference
of foreign exchange statement | 509,764.56 | -495,193.96 | 7. Others | | 1,509,102.69 | After-tax net of other misc.
income attributed to minority
shareholders | 22,494.68 | -23,393.41 | 7. Total of misc. incomes | 113,937,025.21 | 115,162,616.34 | Total of misc. incomes
attributable to the owners of the
parent company | 112,234,943.50 | 111,487,240.59 | Total misc gains attributable
to the minor shareholders | 1,702,081.71 | 3,675,375.75 | 8. Earnings per share: | | | (1) Basic earnings per share | 0.10 | 0.10 | (2) Diluted earnings per share | 0.10 | 0.10 |
Net profit contributed by entities merged under common control in the report period was RMB0.00, net
profit realized by parties merged during the previous period is RMB0.00. Legal representative: Xiong Jianming CFO: Lin Kebing Accounting Manager: Wu Bohua 4. Income Statement of the Parent Company
In RMB
Item | H1 2022 | H1 2021 | 1. Turnover | 14,705,232.50 | 12,068,999.58 | Less: Operation cost | 418,824.01 | 89,904.13 | Taxes and surcharges | 655,596.71 | 664,469.85 | Sales expense | | | Administrative expense | 15,050,027.61 | 13,509,831.81 | R&D cost | | | Financial expenses | 6,762,805.90 | 7,575,722.85 | Including: interest cost | 5,419,166.67 | 7,449,236.11 | Interest income | 216,667.03 | 407,702.78 | Add: other gains | 72,308.39 | 85,100.49 | Investment gains (“-” for
loss) | 431,992.15 | 33,976,138.71 | Incl. Investment gains
from affiliates and joint
ventures | | | Financial assets
derecognised as a result of
amortized cost ("-" for loss) | | | Net open hedge gains (“-”
for loss) | | | Gains from change of fair
value (“-“ for loss) | | | Credit impairment ("-" for
loss) | -12,016.02 | -3,239.44 | Investment impairment loss
("-" for loss) | | | Investment gains ("-" for
loss) | -26,723.69 | -460.17 | 2. Operational profit (“-” for
loss) | -7,716,460.90 | 24,286,610.53 | Plus: non-operational income | 0.84 | 32,837.61 | Less: non-operational
expenditure | 47,636.27 | 101,429.05 | 3. Gross profit ("-" for loss) | -7,764,096.33 | 24,218,019.09 | Less: Income tax expenses | -1,872,231.86 | -2,200,178.64 | 4. Net profit (“-” for net
loss) | -5,891,864.47 | 26,418,197.73 | (1) Net profit from continuous
operation ("-" for net loss) | -5,891,864.47 | 26,418,197.73 | (2) Net profit from
discontinuous operation ("-" for
net loss) | | | 5. After-tax net amount of other
misc. incomes | | 1,509,102.69 | (1) Other misc. incomes that
cannot be re-classified into gain
and loss | | | 1. Re-measure the change in
the defined benefit plan | | | 2. Other comprehensive
income that cannot be transferred
to profit or loss under the
equity method | | | 3. Fair value change of
investment in other equity tools | | | 4. Fair value change of the
Company's credit risk | | | 5. Others | | | (2) Other misc. incomes that
will be re-classified into gain
and loss | | 1,509,102.69 | 1. Other comprehensive
income that can be transferred to
profit or loss under the equity
method | | | 2. Fair value change of
other debt investment | | | 3. Gains and losses from
changes in fair value of
available-for-sale financial
assets | | | 4. Other credit investment
credit impairment provisions | | | 5. Cash flow hedge reserve | | | 6. Translation difference
of foreign exchange statement | | | 7. Others | | 1,509,102.69 | 6. Total of misc. incomes | -5,891,864.47 | 27,927,300.42 | 7. Earnings per share: | | | (1) Basic earnings per share | | | (2) Diluted earnings per share | | |
5. Consolidated Cash Flow Statement
In RMB
Item | H1 2022 | H1 2021 | 1. Net cash flow from business
operations: | | | Cash received from sales of
products and providing of
services | 1,404,641,263.99 | 1 ,573,340,053.10 | Net increase of customer
deposits and capital kept for
brother company | | | Net increase of loans from
central bank | | | Net increase of inter-bank
loans from other financial bodies | | | Cash received against original
insurance contract | | | Net cash received from
reinsurance business | | | Net increase of client deposit
and investment | | | Cash received as interest,
processing fee, and commission | | | Net increase of inter-bank fund
received | | | Net increase of repurchasing
business | | | Net cash received from trading
securities | | | Tax refunded | 13,589,221.42 | 16,480,293.15 | Other cash received from
business operation | 101,615,328.20 | 91,747,818.37 | Sub-total of cash inflow from
business operations | 1,519,845,813.61 | 1,681,568,164.62 | Cash paid for purchasing
products and services | 1,218,828,059.03 | 1,361,468,797.85 | Net increase of client trade
and advance | | | Net increase of savings in
central bank and brother company | | | Cash paid for original contract
claim | | | Net increase in funds | | | dismantled | | | Cash paid for interest,
processing fee and commission | | | Cash paid for policy dividend | | | Cash paid to and for the staff | 224,849,803.47 | 1 9 6,896,028.86 | Taxes paid | 88,742,682.58 | 4 3 1 , 724,633.10 | Other cash paid for business
activities | 294,006,061.57 | 1 9 2,403,249.81 | Sub-total of cash outflow from
business operations | 1,826,426,606.65 | 2 ,182,492,709.62 | Cash flow generated by business
operations, net | -306,580,793.04 | - 500,924,545.00 | 2. Cash flow generated by
investment: | | | Cash received from investment
recovery | 2,282,234,066.40 | 2,224,594,891.08 | Cash received as investment
profit | 2,513,790.26 | 2,754,435.58 | Net cash retrieved from
disposal of fixed assets,
intangible assets, and other
long-term assets | 2,041,120.00 | 332,717.49 | Net cash received from disposal
of subsidiaries or other
operational units | | | Other investment-related cash
received | | | Sub-total of cash inflow
generated from investment | 2,286,788,976.66 | 2,227,682,044.15 | Cash paid for construction of
fixed assets, intangible assets
and other long-term assets | 19,887,603.68 | 54,321,772.94 | Cash paid as investment | 2,389,975,144.00 | 2,167,460,000.00 | Net increase of loan against
pledge | | | Net cash paid for acquiring
subsidiaries and other
operational units | | 125,388,100.00 | Other cash paid for investment | | 1,323,355.15 | Subtotal of cash outflows | 2,409,862,747.68 | 2,348,493,228.09 | Cash flow generated by investment
activities, net | -123,073,771.02 | -120,811,183.94 | 3. Cash flow generated by
financing activities: | | | Cash received from investment | | | Incl. Cash received from
investment attracted by
subsidiaries from minority
shareholders | | | Cash received from borrowed
loans | 1,168,411,688.20 | 1,220,000,000.00 | Other cash received from
financing activities | | | Subtotal of cash inflow from
financing activities | 1,168,411,688.20 | 1,220,000,000.00 | Cash paid to repay debts | 328,500,000.00 | 445,249,952.00 | Cash paid as dividend, profit,
or interests | 102,751,331.27 | 64,069,929.56 | Incl. Dividend and profit paid
by subsidiaries to minority
shareholders | | 4,560,100.00 | Other cash paid for financing
activities | 609,596,798.70 | 5 2 9,360,479.34 | Subtotal of cash outflow from
financing activities | 1,040,848,129.97 | 1 ,038,680,360.90 | Net cash flow generated by
financing activities | 127,563,558.23 | 1 8 1,319,639.10 | 4. Influence of exchange rate
changes on cash and cash
equivalents | 3,757,947.63 | - 6 71 ,353.77 | 5. Net increase in cash and cash
equivalents | -298,333,058.20 | - 441,087,443.61 | Plus: Balance of cash and cash
equivalents at the beginning of
term | 892,251,071.59 | 1,028,386,529.73 | 6. Balance of cash and cash
equivalents at the end of the
period | 593,918,013.39 | 5 87,299,086.12 |
6. Cash Flow Statement of the Parent Company (未完)
|
|